Supplementary protection
LT - Bardoksolonmetilo 2,2-difluorpropionamido dariniai, polimorfinės formos ir jų panaudojimo būdai
EN - 2.2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
SPC
| (11) |
Number of the document |
C 2841445 |
| (68) |
Number of the document |
2841445
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2024 511 |
| (22) |
Date of filing the application |
2024-04-17 |
| (41) |
Date of publication of the application |
2024-05-10 |
|
Date of publication of SPC |
2025-10-10 |
| (24) |
Date of coming into effect of SPC |
2033-04-25 |
Applicant
| (71) |
Reata Pharmaceuticals Holdings, LLC,
5320 Legacy Drive, Plano, Texas 75024,
US
|
Grantee
| (73) |
Reata Pharmaceuticals Holdings, LLC,
5320 Legacy Drive, Plano, Texas 75024,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/23/1786, 2024-02-09
|
Calculated date of expiry of the SPC
| (94) |
2038-04-24 |
Name of the product protected by the basic patent
| (95) |
Omaveloksolonas arba farmaciniu požiūriu priimtina jo druska |
